Advanced Drug Delivery Systems

Development of lipid-based nanoparticles, liposomes, or other molecular platforms to encapsulate and deliver therapeutic agents, particularly nucleic acids, to target tissues or improve pharmacokinetics.

11,068 US filings from 3,995 companies since 2023 · 2023: 2,653 · 2024: 3,470 · 2025: 3,495 · 2026 YTD: 1,450

NanotechnologyAcyclic / Carbocyclic CompoundsAcyclic / Cyclic Compounds (Other Elements)

Top companies

Ranked by filings in this theme since 2023. 2026 is partial.

#	Company	Since 2023	2023	2024	2025	2026 YTD	YoY
1	The Regents of the University of California	188	48	51	69	20	+35.3%
2	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	130	37	32	46	15	+43.8%
3	The Johns Hopkins University	105	33	32	29	11	-9.4%
4	ModernaTX, Inc.	96	21	25	34	16	+36.0%
5	UNIVERSITY OF MASSACHUSETTS	90	23	31	29	7	-6.5%
6	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	83	16	24	33	10	+37.5%
7	TRANSLATE BIO, INC.	77	12	28	27	10	-3.6%
8	Northwestern University	73	13	23	27	10	+17.4%
9	GlaxoSmithKline Biologicals SA	70	40	20	7	3	-65.0%
10	President and Fellows of Harvard College	70	15	21	28	6	+33.3%
11	Alnylam Pharmaceuticals, Inc.	67	15	25	23	4	-8.0%
12	Yale University	64	14	28	17	5	-39.3%
13	Dyne Therapeutics, Inc.	63	15	20	25	3	+25.0%
14	The Board of Regents of The University of Texas System	60	13	32	12	3	-62.5%
15	Ohio State Innovation Foundation	59	8	16	20	15	+25.0%
16	Board of Regents, The University of Texas System	57	16	19	14	8	-26.3%
17	The Board of Trustees of the Leland Stanford Junior University	57	11	24	13	9	-45.8%
18	The University of North Carolina at Chapel Hill	53	12	14	20	7	+42.9%
19	Emory University	50	10	19	18	3	-5.3%
20	The Regents of the University of Michigan	50	18	15	14	3	-6.7%
21	The General Hospital Corporation	47	12	12	16	7	+33.3%
22	CASE WESTERN RESERVE UNIVERSITY	46	11	16	15	4	-6.2%
23	Regeneron Pharmaceuticals, Inc.	46	5	13	20	8	+53.8%
24	CORNELL UNIVERSITY	45	15	14	11	5	-21.4%
25	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED	44	12	13	9	10	-30.8%